Chimeric antigen receptor T (CAR-T) cells expanded with IL-7/IL-15 mediate superior antitumor effects

被引:97
作者
Zhou, Jianxia [1 ,2 ]
Jin, Liyuan [1 ,2 ]
Wang, Fuping [1 ,4 ]
Zhang, Yuan [1 ,2 ]
Liu, Bing [3 ]
Zhao, Tongbiao [1 ,2 ]
机构
[1] Chinese Acad Sci, State Key Lab Reprod Biol, Inst Zool, Beijing 100101, Peoples R China
[2] Chinese Acad Sci, Grad Univ, Beijing 100049, Peoples R China
[3] Acad Mil Med Sci, State Key Lab Prote, Translat Med Ctr Stem Cells, Ivy Translat Med Ctr 307,Lab Oncol,Affiliated Hos, Beijing 100071, Peoples R China
[4] Hebei Univ, Coll Life Sci, Baoding 071002, Peoples R China
基金
中国国家自然科学基金; 国家重点研发计划;
关键词
IMMUNOGLOBULIN; THERAPY; IL-7;
D O I
10.1007/s13238-019-0643-y
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
引用
收藏
页码:764 / 769
页数:6
相关论文
共 50 条
[41]   Theranostic chimeric antigen receptor (CAR)-T cells: Insight into recent trends and challenges in solid tumors [J].
Kheyrolahzadeh, Keyvan ;
Tohidkia, Mohammad Reza ;
Tarighatnia, Ali ;
Shahabi, Parviz ;
Nader, Nader D. ;
Aghanejad, Ayuob .
LIFE SCIENCES, 2023, 328
[42]   Chimeric Antigen receptor-T (CAR-T) cells targeting Epithelial cell adhesion molecule (EpCAM) can inhibit tumor growth in ovarian cancer mouse model [J].
Fu, Juan ;
Shang, Yuhong ;
Qian, Zhang ;
Hou, Jinping ;
Yan, Feng ;
Liu, Guodi ;
Li Dehua ;
Tian, Xiaoli .
JOURNAL OF VETERINARY MEDICAL SCIENCE, 2021, 83 (02) :241-247
[43]   Clinical practice: chimeric antigen receptor (CAR) T cells: a major breakthrough in the battle against cancer [J].
Lundh, Stefan ;
Jung, In-Young ;
Dimitri, Alexander ;
Vora, Anish ;
Melenhorst, J. Joseph ;
Jadlowsky, Julie K. ;
Fraietta, Joseph A. .
CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 20 (04) :469-480
[44]   Reducing Ex Vivo Culture Improves the Antileukemic Activity of Chimeric Antigen Receptor (CAR) T Cells [J].
Ghassemi, Saba ;
Nunez-Cruz, Selene ;
O'Connor, Roddy S. ;
Fraietta, Joseph A. ;
Patel, Prachi R. ;
Scholler, John ;
Barrett, David M. ;
Lundh, Stefan M. ;
Davis, Megan M. ;
Bedoya, Felipe ;
Zhang, Changfeng ;
Leferovich, John ;
Lacey, Simon F. ;
Levine, Bruce L. ;
Grupp, Stephan A. ;
June, Carl H. ;
Melenhorst, J. Joseph ;
Milone, Michael C. .
CANCER IMMUNOLOGY RESEARCH, 2018, 6 (09) :1100-1109
[45]   Performance-enhancing drugs: design and production of redirected chimeric antigen receptor (CAR) T cells [J].
Levine, B. L. .
CANCER GENE THERAPY, 2015, 22 (02) :79-84
[46]   Proliferation-Linked Apoptosis of Adoptively Transferred T Cells after IL-15 Administration in Macaques [J].
Berger, Carolina ;
Berger, Michael ;
Beard, Brian C. ;
Kiem, Hans-Peter ;
Gooley, Theodore A. ;
Riddell, Stanley R. .
PLOS ONE, 2013, 8 (02)
[47]   Armored Inducible Expression of IL-12 Enhances Antitumor Activity of Glypican-3-Targeted Chimeric Antigen Receptor-Engineered T Cells in Hepatocellular Carcinoma [J].
Liu, Ying ;
Di, Shengmeng ;
Shi, Bizhi ;
Zhang, Honghong ;
Wang, Yi ;
Wu, Xiuqi ;
Luo, Hong ;
Wang, Huamao ;
Li, Zonghai ;
Jiang, Hua .
JOURNAL OF IMMUNOLOGY, 2019, 203 (01) :198-207
[48]   Combining the best of two worlds: highly flexible chimeric antigen receptor adaptor molecules (CAR-adaptors) for the recruitment of chimeric antigen receptor T cells [J].
Darowski, Diana ;
Kobold, Sebastian ;
Jost, Christian ;
Klein, Christian .
MABS, 2019, 11 (04) :621-631
[49]   The construction of modular universal chimeric antigen receptor T (MU-CAR-T) cells by covalent linkage of allogeneic T cells and various antibody fragments [J].
Chen, Tao ;
Deng, Jieyi ;
Zhang, Yongli ;
Liu, Bingfeng ;
Liu, Ruxin ;
Zhu, Yiqiang ;
Zhou, Mo ;
Lin, Yingtong ;
Xia, Baijin ;
Lin, Keming ;
Ma, Xiancai ;
Zhang, Hui .
MOLECULAR CANCER, 2024, 23 (01)
[50]   Potent anti-leukemia activities of humanized CD19-targeted Chimeric antigen receptor T (CAR-T) cells in patients with relapsed/refractory acute lymphoblastic leukemia [J].
Cao, Jiang ;
Wang, Gang ;
Cheng, Hai ;
Wei, Chen ;
Qi, Kunming ;
Sang, Wei ;
Li Zhenyu ;
Shi, Ming ;
Li, Huizhong ;
Qiao, Jianlin ;
Pan, Bin ;
Zhao, Jing ;
Wu, Qingyun ;
Zeng, Lingyu ;
Niu, Mingshan ;
Jing, Guangjun ;
Zheng, Junnian ;
Xu, Kailin .
AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (07) :851-858